Foresite Capital Raises $969 Million to Invest in Early to Late-Stage Companies Transforming Healthcare
Foresite Capital Raises $969 Million to Invest in Early to Late-Stage Companies Transforming Healthcare
02/25/21, 7:02 PM
Location
san franciscoMoney raised
$969 million
Foresite Capital, a multi-stage healthcare and life sciences investment firm, today announced it has closed its fifth and largest fundraise with $969 million in capital commitments, significantly oversubscribed above its original target. The offering comprises Foresite Capital Fund V, L.P. and Foresite Capital Opportunity Fund V, L.P. With these new funds, Foresite Capital is investing in emerging healthcare and life sciences companies at all stages that are solving some of the biggest inefficiencies and pain points of the $10 trillion global healthcare market
Company Info
Location
san francisco, california, united states
Additional Info
Foresite Capital is a multi-stage healthcare and life sciences investment firm with approximately $4 billion in assets under management. The firm aims to address areas of great unmet need by funding promising healthcare and life sciences businesses at all stages of their life cycles. Foresite Capital uses a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare. Founded in 2011, Foresite Capital is based in the San Francisco Bay Area and New York City. For more information, please visit www.foresitecapital.com.